Compare AGIO & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | IMKTA |
|---|---|---|
| Founded | 2007 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2013 | 1994 |
| Metric | AGIO | IMKTA |
|---|---|---|
| Price | $34.45 | $90.19 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $39.88 | N/A |
| AVG Volume (30 Days) | ★ 969.5K | 105.6K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $43,011,000.00 | ★ $5,334,032,609.00 |
| Revenue This Year | $74.95 | N/A |
| Revenue Next Year | $165.77 | N/A |
| P/E Ratio | ★ N/A | $15.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.24 | $59.09 |
| 52 Week High | $46.00 | $95.62 |
| Indicator | AGIO | IMKTA |
|---|---|---|
| Relative Strength Index (RSI) | 66.34 | 54.50 |
| Support Level | $26.64 | $68.14 |
| Resistance Level | $36.35 | N/A |
| Average True Range (ATR) | 1.38 | 2.21 |
| MACD | 0.08 | -0.13 |
| Stochastic Oscillator | 71.17 | 56.10 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.